Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 4.21% vs 574.06% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is -67.16% vs -116.11% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 34.48% vs 106.65% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 532.16% vs 1.53% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024
Compare Quarterly Results Of Nxera Pharma Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 27.18% vs -3.04% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 4.21% vs 574.06% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -212.76% vs 43.07% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -67.16% vs -116.11% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 111.16% vs 25.20% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 34.48% vs 106.65% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 405.22% vs 22.06% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 532.16% vs 1.53% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has fallen from Jun 2024






